These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

459 related items for PubMed ID: 17959252

  • 1. Comparison of biochemical effects of statins and fish oil in brain: the battle of the titans.
    Farooqui AA, Ong WY, Horrocks LA, Chen P, Farooqui T.
    Brain Res Rev; 2007 Dec; 56(2):443-71. PubMed ID: 17959252
    [Abstract] [Full Text] [Related]

  • 2. Lipid mediators in the neural cell nucleus: their metabolism, signaling, and association with neurological disorders.
    Farooqui AA.
    Neuroscientist; 2009 Aug; 15(4):392-407. PubMed ID: 19666894
    [Abstract] [Full Text] [Related]

  • 3. Lipid mediators and their metabolism in the nucleous: implications for Alzheimer's disease.
    Farooqui AA.
    J Alzheimers Dis; 2012 Aug; 30 Suppl 2():S163-78. PubMed ID: 21955817
    [Abstract] [Full Text] [Related]

  • 4. Modulation of inflammation in brain: a matter of fat.
    Farooqui AA, Horrocks LA, Farooqui T.
    J Neurochem; 2007 May; 101(3):577-99. PubMed ID: 17257165
    [Abstract] [Full Text] [Related]

  • 5. Fatty acid facts, Part III: Cardiovascular disease, or, a fish diet is not fishy.
    Pauwels EK, Kostkiewicz M.
    Drug News Perspect; 2008 Dec; 21(10):552-61. PubMed ID: 19221636
    [Abstract] [Full Text] [Related]

  • 6. Interactions between neural membrane glycerophospholipid and sphingolipid mediators: a recipe for neural cell survival or suicide.
    Farooqui AA, Horrocks LA, Farooqui T.
    J Neurosci Res; 2007 Jul; 85(9):1834-50. PubMed ID: 17393491
    [Abstract] [Full Text] [Related]

  • 7. Fish oil feeding attenuates neuroinflammatory gene expression without concomitant changes in brain eicosanoids and docosanoids in a mouse model of Alzheimer's disease.
    Hopperton KE, Trépanier MO, James NCE, Chouinard-Watkins R, Bazinet RP.
    Brain Behav Immun; 2018 Mar; 69():74-90. PubMed ID: 29109025
    [Abstract] [Full Text] [Related]

  • 8. Fish oil lipid emulsions and immune response: what clinicians need to know.
    Waitzberg DL, Torrinhas RS.
    Nutr Clin Pract; 2009 Mar; 24(4):487-99. PubMed ID: 19605803
    [Abstract] [Full Text] [Related]

  • 9. Potential therapeutic role of statins in neurological disorders.
    Bifulco M, Malfitano AM, Marasco G.
    Expert Rev Neurother; 2008 May; 8(5):827-37. PubMed ID: 18457539
    [Abstract] [Full Text] [Related]

  • 10. Immunomodulatory effects of HMG-CoA reductase inhibitors.
    Danesh FR, Anel RL, Zeng L, Lomasney J, Sahai A, Kanwar YS.
    Arch Immunol Ther Exp (Warsz); 2003 May; 51(3):139-48. PubMed ID: 12894868
    [Abstract] [Full Text] [Related]

  • 11. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases.
    Calder PC.
    Mol Nutr Food Res; 2008 Aug; 52(8):885-97. PubMed ID: 18504706
    [Abstract] [Full Text] [Related]

  • 12. Essential fatty acids as possible mediators of the actions of statins.
    Das UN.
    Prostaglandins Leukot Essent Fatty Acids; 2001 Jul; 65(1):37-40. PubMed ID: 11487306
    [Abstract] [Full Text] [Related]

  • 13. How do statins control neuroinflammation?
    Adamson P, Greenwood J.
    Inflamm Res; 2003 Oct; 52(10):399-403. PubMed ID: 14520514
    [Abstract] [Full Text] [Related]

  • 14. Antioxidative effects of statins.
    Adam O, Laufs U.
    Arch Toxicol; 2008 Dec; 82(12):885-92. PubMed ID: 18670762
    [Abstract] [Full Text] [Related]

  • 15. Effects of HMG-CoA reductase inhibitors on endothelial function: role of microdomains and oxidative stress.
    Mason RP, Walter MF, Jacob RF.
    Circulation; 2004 Jun 01; 109(21 Suppl 1):II34-41. PubMed ID: 15173061
    [Abstract] [Full Text] [Related]

  • 16. [The pleiotropic effects of statins].
    Wolfovitz E.
    Harefuah; 2005 Aug 01; 144(8):577-82, 597. PubMed ID: 16146158
    [Abstract] [Full Text] [Related]

  • 17. [Examples of results of pharmaceutical cerebrovascular protection, with special emphasis on the statins].
    Bajnok L.
    Ideggyogy Sz; 2011 Mar 30; 64(5-6):151-6. PubMed ID: 21692273
    [Abstract] [Full Text] [Related]

  • 18. Statins--a cure-all for the brain?
    Menge T, Hartung HP, Stüve O.
    Nat Rev Neurosci; 2005 Apr 30; 6(4):325-31. PubMed ID: 15803163
    [Abstract] [Full Text] [Related]

  • 19. Statins: mechanisms of neuroprotection.
    van der Most PJ, Dolga AM, Nijholt IM, Luiten PG, Eisel UL.
    Prog Neurobiol; 2009 May 30; 88(1):64-75. PubMed ID: 19428962
    [Abstract] [Full Text] [Related]

  • 20. Impact of HMG-CoA reductase inhibition on brain pathology.
    Zipp F, Waiczies S, Aktas O, Neuhaus O, Hemmer B, Schraven B, Nitsch R, Hartung HP.
    Trends Pharmacol Sci; 2007 Jul 30; 28(7):342-9. PubMed ID: 17573124
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.